IRCT20141127020112N8
Completed
Phase 3
Comparision of glargine insulin and Regular insulin on quality of perioperative glucose control in type2 diabetic patient undergoing viterectomy under general anesthesia
Overview
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 80
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 30 years to 70 years (—)
- Sex
- All
Inclusion Criteria
- •Age: 30\-70 years old
- •Duration of diabetes for more than three months
- •New York Heart Association (NYHA) class 1 or 2
Exclusion Criteria
- •Diabetic ketoacidosis or its history
- •Renal failure
- •Liver failure
- •Hypoglycemia episodes in a hospital
- •Hyperglycemia without a history of diabetes
- •Patients or psychiatric disorders that can not provide information
- •Corticosteroid use
- •Infection and sepsis
- •BMI more than 35
Investigators
Similar Trials
Recruiting
Not Applicable
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010715Mie Chuo Medical Center30
Active, not recruiting
Not Applicable
Comparative investigation of Insuline glargine versus Metformin as first line drug in treat-ment of early Type 2 Diabetes (GLORY) - GLORYDiabetes mellitus Type IIMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-006860-12-DEGWT-TUD GmbH100
Active, not recruiting
Not Applicable
Impact of Insulin Glargine compared to Insulin Detemir in combination with Metformin (BOT) on prandial beta cell function and overall metabolic control in type 2 diabetic patients with insufficient metabolic control during OAD Treatment - Insulin glargine and prandial beta cell functionDiabetes mellitus Type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-006109-26-DEInstitut für Klinische Forschung und Entwicklung (ikfe) GmbH
Not yet recruiting
Not Applicable
Comparison study between insulin glargine and decludec on the glucose fluctuation in Type 2 diabetic patients treated with basal insulin and oral hypoglycemic agents.JPRN-UMIN000012138Kyorin University of Medicine30
Active, not recruiting
Not Applicable
Superiority study of insulin glargine over sitagliptin in insulin-naïve patients with type 2 diabetes treated with metformin and not adequately controlled - EASIEType 2 diabetes treated with metformin and not adequately controlledMedDRA version: 9.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlEUCTR2008-000516-32-GRsanofi aventis Groupe530